Cu(II)ATSM

N/A

Report date: 2025/09/08 16:21:19
NME

Base Information

Drug NameCu(II)ATSM
Drug Alias NameCopper(II)-diacetyl-di(N4-methylthiosemicarbazone)Diacetylbis(N(4)-methylthiosemicarbazonato) copper(II)Cu-diacetyl-bis(N4-methylthiosemicarbazonate)Cu-ATSMCopper(II)-ATSM
ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Copper > 64CuRadiation-emitting products > Radionuclide Drug Conjugates
Mechanisms of ActionNeurons modulators
TargetsNot applicable
Therapy Area/IndicationsMotor Neuron DiseaseAmyotrophic Lateral SclerosisParkinson Disease +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaFrance
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Melbourne
China Registration ClassN/A

Develop Information

Active CompaniesInstitut De Cancerologie De L Ouest
Inactive CompaniesCollaborative Medicinal Development Pty LtdNational Cancer Institute
Active IndicationsRectal Neoplasms
Inactive IndicationsMotor Neuron DiseaseAmyotrophic Lateral SclerosisParkinson Disease +[4] 

Other Information

ATC CodeN/A
Related LinksN/A